Influence of steep Trendelenburg position on postoperative complications: a systematic review and meta-analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1863-2491
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Influence of steep Trendelenburg position on postoperative complications: a systematic review and meta-analysis ; day:31 ; month:12 ; year:2021 ; pages:1-15
Journal of robotic surgery ; (31.12.2021), 1-15
- Creator
-
Katayama, Satoshi
Mori, Keiichiro
Pradere, Benjamin
Yanagisawa, Takafumi
Mostafaei, Hadi
Quhal, Fahad
Motlagh, Reza Sari
Laukhtina, Ekaterina
Grossmann, Nico C.
Rajwa, Pawel
Aydh, Abdulmajeed
König, Frederik
Karakiewicz, Pierre I.
Araki, Motoo
Nasu, Yasutomo
Shariat, Shahrokh F.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11701-021-01361-x
- URN
-
urn:nbn:de:101:1-2022042020112648626709
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Katayama, Satoshi
- Mori, Keiichiro
- Pradere, Benjamin
- Yanagisawa, Takafumi
- Mostafaei, Hadi
- Quhal, Fahad
- Motlagh, Reza Sari
- Laukhtina, Ekaterina
- Grossmann, Nico C.
- Rajwa, Pawel
- Aydh, Abdulmajeed
- König, Frederik
- Karakiewicz, Pierre I.
- Araki, Motoo
- Nasu, Yasutomo
- Shariat, Shahrokh F.
- SpringerLink (Online service)
Other Objects (12)
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Focal therapy in intermediate- and high-risk prostate cancer
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant
ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer?
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Focal therapy in intermediate- and high-risk prostate cancer
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant
ASO Author Reflections: Is There Any Difference Among Various Gleason Scores Classified as Grade Group 4 Prostate Cancer?
Prostatakrebs : Vorbeugung, Diagnose; Therapie
Medical practice and placebo response: an inseparable bond?
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Association of patients’ sex with treatment outcomes after intravesical bacillus Calmette–Guérin immunotherapy for T1G3/HG bladder cancer
PD-1 and PD-L1 inhibitors after platinum-based chemotherapy or in first-line therapy in cisplatin-ineligible patients : Dramatic improvement of prognosis and overall survival after decades of hopelessness in patients with metastatic urothelial cancer
Focal therapy in intermediate- and high-risk prostate cancer
Neoadjuvant therapy in urothelial cancer : New therapies on the horizon
Association of super-extended lymphadenectomy at radical cystectomy with perioperative complications and re-hospitalization
Evidence and emerging trends in local therapy for metastatic hormone-sensitive prostate cancer: a narrative review
ASO Author Reflections: Is Vascular Cell Adhesion Molecule-1 (VCAM-1) a Promising Biomarker in Urothelial Carcinoma of the Bladder?
Increased risk of postoperative in-hospital complications after radical prostatectomy in patients with prior organ transplant